Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
types of TB therapy
|
preventative
tx of active disease |
|
classification of 1st versus 2nd line drugs is based on what
|
efficacy
risk of drug toxicity |
|
first line TB drugs
|
streptomycin
rifampin isoniazid pyrazinamide ethambutol |
|
first line drug with a lot of side effects and that is not used often as first line
|
streptomycin
|
|
1st line drug that provides coverage for rifampin and isoniazid resistant TB
|
ethambutol
|
|
TB drugs that have a 95% cure rate in 9 mo
|
rifampin
isoniazid |
|
TB drugs that inhibit the cell wall
|
isoniazid
ethambutol |
|
TB drugs that inhibit protein synthesis
|
pyrazinamide
|
|
TB drug that inhibits RNA synthesis
|
rifampin
|
|
reasons TB is hard to treat
|
slow growing
can be dormant lipid rich cell wall infection inside host cell |
|
probability of drug resistance
|
1 in 10^6
|
|
number of bacteria usually present in infection
|
10^8
|
|
1st line drug for latent TB infection
|
isoniazid
|
|
isoniazid is bacteristatic or bactericidal
|
bactericidal
|
|
isoniazid is what kind of drug (metabolically)
|
prodrug: needs to be activated
|
|
mechanism of resistance to isoniazid
|
decreased activation of drug
|
|
isoniazid metabolism
|
acetylated and cleared by liver
|
|
isoniazid is excreted in urine in what form
|
metabolite
|
|
drug drug interaction considerations with isoniazid
|
inhibits CYP 3A4
|
|
side effects of isoniazid
|
inhibits neurons and hepatocytes
drug induced hepatitis peirpheral neuropathy and CNS toxicity |
|
most important risk factor for isonizid induced hepatitis
|
age
|
|
alternative treatment of latent TB infection
|
rifampin
|
|
why is there no cross resistance between the 1st line drugs
|
all work by different mechanisms
|
|
bactericidal first line drugs
|
isoniazid
rifampin pyrazinamide streptomycin |
|
bacteriostatic first line drugs
|
ethambutol
|
|
which first line drug is not orally effective
|
streptomycin
|
|
which first line drug is not hepatotoxic
|
streptomycin
ethambutol |
|
first line drugs that are hepatotoxic
|
rifampin
isoniazid pyrazinamide |
|
rifampin side effects
|
hepatitis
fllu like syndrome red fluids |
|
pyrazinamide side effects
|
hepatotoxicity
hyperuricemia |
|
ethambutol side effects
|
optic neuritis
hyperuricemia |
|
streptomycin side effects
|
ototoxicity
nephrotoxicity |
|
first line drug that doesnt bind well to human enzymes (selective toxicity)
|
rifampin
|
|
first line drug that causes ototoxicity
|
streptomycin
|
|
first line drug where age is most important factor in determining hepatotoxicity
|
isoniazid
|
|
first line drug with significant interactions with protease
inhibitors and non-nucleoside reverse transcriptase inhibitors NNRTIs |
rifampin
|
|
rifampin has what effect on NNRTI and PI blood levels
|
decreases
|
|
drug used to avoid PI and NNRTI interaction with rifampin
|
rifabutin
|
|
least effective first line drug
|
ethambutol
|
|
when is streptomycin indicated for TB treatment
|
life threatening disease
drug-resistant infection |
|
recommended initial and continuation therapy for the treatment of
active TB infection in the general population in the absence of isoniazid resistanc |
initial (2 mo): INH, RIF, PZA, and ETB
continuation (4 mo): INH, RIF |
|
recommended initial and continuation therapy for the treatment of active TB infection in the general population in the presence of isoniazid
resistance |
initial (6 mo): RIF, PZA, ETB
continuation: none |